Recce Pharmaceuticals Ltd
ASX:RCE
Recce Pharmaceuticals Ltd
Net Income (Common)
Recce Pharmaceuticals Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Recce Pharmaceuticals Ltd
ASX:RCE
|
Net Income (Common)
-AU$11.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Net Income (Common)
AU$117.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Net Income (Common)
AU$157.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Net Income (Common)
-AU$14.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-24%
|
|
Probiotec Ltd
ASX:PBP
|
Net Income (Common)
AU$8.7m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
21%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Net Income (Common)
-AU$24.6m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Recce Pharmaceuticals Ltd's Net Income (Common)?
Net Income (Common)
-11.3m
AUD
Based on the financial report for Dec 31, 2023, Recce Pharmaceuticals Ltd's Net Income (Common) amounts to -11.3m AUD.
What is Recce Pharmaceuticals Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-46%
Over the last year, the Net Income (Common) growth was 26%. The average annual Net Income (Common) growth rates for Recce Pharmaceuticals Ltd have been 5% over the past three years , -46% over the past five years .